US 8,940,761 B2Granted

[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors

AssigneeLeo Pharma A/S

InventorsSimon Feldbæk Nielsen, Jens Christian Højland Larsen

Life of this patent

Estimating the term…

Abstract

The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.

Claims10

Dependent claims

A compound of general formula (I)

any of its stereoisomers or any mixture of its stereoisomers or a pharmaceutically acceptable salt thereof, wherein R is branched butyl.

Dependencies are inferred from the claim text.

Facts

Application: 14/361,356Filed 19 Dec 2012 · us provisional application
Priority: 21 Dec 2011
Published: US 2014/0329853 A16 Nov 2014
Granted: 27 Jan 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 31/437
Ortho- or peri-condensed with heterocyclic ring systems: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring…
A61P 11/06
Drugs for disorders of the respiratory system: antiasthmatics
A61P 17/00
Drugs for dermatological disorders

Family

Application61/578,677Us provisional application · filed 21 Dec 2011
Application61/666,430Us provisional application · filed 29 Jun 2012
US 2014/0329853 A1Pre-grant publication · published 6 Nov 2014
US 8,940,761 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results